Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in Refractory Partial Epilepsy
NCT00236847Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Dec 1989
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of topiramate in partial epilepsy, sponsored by Johnson & Johnson. Started Dec 1989; status: completed.
02
Drugs
topiramate
03
Conditions
partial epilepsy
Beyond the preview
Go deeper on NCT00236847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00236847.